WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SF 3299

Legislative bill overview

SF 3299 establishes fair pricing requirements for reimbursement of community pharmacies by insurance plans and pharmacy benefit managers (PBMs). The bill aims to ensure that pharmacies receive adequate compensation for dispensing medications and related services, addressing concerns about unsustainably low reimbursement rates that threaten pharmacy viability.

Why is this important

Community pharmacies provide essential healthcare access, medication counseling, and local health services, particularly in rural and underserved areas. Inadequate reimbursement rates have forced many independent pharmacies to close, reducing medication access and shifting costs to hospital systems and emergency services. Fair pricing standards could stabilize this critical healthcare infrastructure.

Potential points of contention

  • PBM and insurer opposition: Insurance companies and pharmacy benefit managers argue that lower reimbursement rates help keep overall drug costs down for consumers and employers; they may claim the bill limits their cost-control mechanisms
  • Definition of "fair" pricing: The bill's success depends heavily on how "fair pricing" is defined and calculated—disputes over methodology could lead to implementation challenges and litigation
  • Market impact concerns: Opponents may argue that mandated higher reimbursement rates could increase insurance premiums or drug costs for consumers, while supporters counter this cost is offset by improved access and reduced emergency care usage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.